Principal at ChemTract Consulting

Co-inventor of Caspofungin, the first glucan synthase inhibitor (GSi) for the treatment of serious fungal infections

Former Head of the Infectious Diseases & Vaccines Innovative Medicines unit (iMED) at MedImmune

Former VP and Global Head of Infectious Diseases at the Novartis Institutes for Biomedical Research

Associate Professor

Pharmacology, Physiology & Neuroscience

New Jersey Medical School

Rutgers University

Head of ADC Innovation

Iksuda Therapeutics